Blood consumption in the Role 2 setting: A Department of Defense Trauma Registry analysis

• DOI: 10.1111/trf.17741
• Publication Date: 2024-02-16T07:33:31Z
• Authors: Kelly K. McWhirter; Michael D. April; Andrew D. Fisher; Franklin L. Wright; Julie A. Rizzo; Jason B. Corley; Todd M. Getz; Steven G. Schauer
• Keywords: Blood product

Abstract Background The Role 2 setting represents the most far‐forward military treatment facility with limited surgical and holding capabilities. There are data to guide recommendations on blood product utilization at 2. We describe consumption of products in this setting. Study Design Methods analyzed from 2007 2023 Department Defense Trauma Registry (DODTR) that received care a used descriptive inferential statistics characterize volumes consumed also performed secondary analysis US military, Coalition, contractor personnel. Results Within our initial cohort 15,581 encounters, 17% (2636) least one unit PRBCs or whole blood, which 11% submassive transfusion, 4% massive 1% supermassive transfusion. were 6402 encounters met inclusion for analysis. With group, 5% 2% Conclusions described during recent conflicts. maximum number units among survivors exceeds currently recommended available supply. Our findings suggest rapid resupply cold‐stored chain demands may be higher than anticipated future